Phosphodiesterase type 5 inhibitors: unmet needs
K Hatzimouratidis… - Current pharmaceutical …, 2009 - ingentaconnect.com
Erectile dysfunction (ED) has been revolutionized during the last two decades, as several
treatment options are available today. Phosphodiesterase type 5 (PDE5) inhibitors …
treatment options are available today. Phosphodiesterase type 5 (PDE5) inhibitors …
Phosphodiesterase type 5 inhibitors: unmet needs
K Hatzimouratidis… - Current pharmaceutical …, 2009 - pubmed.ncbi.nlm.nih.gov
Erectile dysfunction (ED) has been revolutionized during the last two decades, as several
treatment options are available today. Phosphodiesterase type 5 (PDE5) inhibitors …
treatment options are available today. Phosphodiesterase type 5 (PDE5) inhibitors …
[引用][C] Phosphodiesterase Type 5 Inhibitors: Unmet Needs: Phosphodieterase-5 Inhibitors and their Use in the Treatment of Urological Conditions
K HATZIMOURATIDIS… - Current …, 2009 - pascal-francis.inist.fr
Phosphodiesterase Type 5 Inhibitors: Unmet Needs : Phosphodieterase-5 Inhibitors and
their Use in the Treatment of Urological Conditions CNRS Inist Pascal-Francis CNRS …
their Use in the Treatment of Urological Conditions CNRS Inist Pascal-Francis CNRS …
Phosphodiesterase type 5 inhibitors: unmet needs.
K Hatzimouratidis, DG Hatzichristou - Current Pharmaceutical …, 2009 - europepmc.org
Erectile dysfunction (ED) has been revolutionized during the last two decades, as several
treatment options are available today. Phosphodiesterase type 5 (PDE5) inhibitors …
treatment options are available today. Phosphodiesterase type 5 (PDE5) inhibitors …